Influence of radiation quality on mouse chromosome 2 deletions in radiation-induced acute myeloid leukaemia

Natalie Brown, Rosemary Finnon, Grainne Manning, Simon Bouffler, Christophe Badie*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)


Leukaemia is the prevailing neoplastic disorder of the hematopoietic system. Epidemiological analyses of the survivors of the Japanese atomic bombings show that exposure to ionising radiation (IR) can cause leukaemia. Although a clear association between radiation exposure and leukaemia development is acknowledged, the underlying mechanisms remain incompletely understood. A hemizygous deletion on mouse chromosome 2 (del2) is a common feature in several mouse strains susceptible to radiation-induced acute myeloid leukaemia (rAML). The deletion is an early event detectable 24 h after exposure in bone marrow cells. Ultimately, 15-25% of exposed animals develop AML with 80-90% of cases carrying del2. Molecular mapping of leukaemic cell genomes identified a minimal deleted region (MDR) on chromosome 2 (chr2) in which a tumour suppressor gene, Sfpi1 is located, encoding the transcription factor PU.1, essential in haematopoiesis. The remaining copy of Sfpi1 has a point mutation in the coding sequence for the DNA-binding domain of the protein in 70% of rAML, which alters a single CpG sequence in the codon for arginine residue R235. In order to identify chr2 deletions and Sfpi.1/PU.1 loss, we performed array comparative genomic hybridization (aCGH) on a unique panel of 79rAMLs. Using a custom made CGH array specifically designed for mouse chr2, we analysed at unprecedentedly high resolution (1.4. M array- 148 bp resolution) the size of the MDR in low LET and high-LET induced rAMLs (32 X-ray- and 47 neutron-induced). Sequencing of Sfpi1/PU.1DNA binding domain identified the presence of R235 point mutations, showing no influence of radiation quality on R235 type or frequency. We identified for the first time rAML cases with complex del2 in a subset of neutron-induced AMLs. This study allowed us to re-define the MDR to a much smaller 5.5. Mb region (still including Sfpi1/PU.1), identical regardless of radiation quality.

Original languageEnglish
Pages (from-to)48-54
Number of pages7
JournalMutation Research - Genetic Toxicology and Environmental Mutagenesis
Publication statusPublished - 22 Jul 2015

Bibliographical note

Funding Information:
This work was funded by Public Health England and was supported by the European Union FP7 EURATOM DoReMi network of excellence [Grant agreement 249689 ] and RISK-IR (Risk, Stem Cells and Tissue Kinetics—Ionising Radiation) , [Grant agreement 323267 ].

Publisher Copyright:
© 2015 Published by Elsevier B.V.


  • ACGH
  • Chromosome deletion
  • Mouse model
  • Myeloid leukemia
  • Radiation
  • Sfpi1/PU.1


Dive into the research topics of 'Influence of radiation quality on mouse chromosome 2 deletions in radiation-induced acute myeloid leukaemia'. Together they form a unique fingerprint.

Cite this